Pelage is a clinical-stage regenerative medicine company developing novel treatments for hair loss, including androgenetic alopecia. Based on discoveries in stem cell biology made by Pelage's scientific co-founders, the company's novel approach is designed to reactivate dormant hair follicle stem cells and restore the body's ability to grow hair naturally.
Company Details
- Employees
- 11
- Founded
- 2018
- Address
- 907 Westwood Blvd, #384, Los Angeles,california 90024,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://pelagepharma.com/
- Keywords
- Biotechnology Research, Hair Loss, Dermatology, Regenerative Medicine, Hair Follicle Regeneration, Therapeutic Innovation, Clinical Trials, Androgenetic Alopecia, Telogen Effluvium, Chemotherapy-induced Hair Loss, Anti-aging.
- HQ
- Los Angeles, California
Pelage Pharmaceuticals Questions
Pelage Pharmaceuticals's website is https://pelagepharma.com/
Pelage Pharmaceuticals's LinkedIn profile is https://www.linkedin.com/company/pelage-pharmaceuticals
Pelage Pharmaceuticals has
11 employees.
View email and phone details for 11
employees at Pelage Pharmaceuticals.
Pelage Pharmaceuticals's industry is
Biotechnology Research
Pelage Pharmaceuticals's top competitors are
Setpoint,
Chowbus,
Ambercycle,
Odyssey Therapeutics,
Voyceme,
Boatsetter,
Pelagen,
Spline,
Gv (Google Ventures),
Kira Pharmaceuticals.
Pelage Pharmaceuticals's categories are Biotechnology Research
Pelage Pharmaceuticals's founding year is 2018
